Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Ho and colleagues (J Chromatogr A, 2012), developing doping-control assays, characterised a veterinary preparation sold as TB-500 that contained only the heptapeptide LKKTETQ, the actin-binding active site spanning residues 17 to 23 of T4
Portillo Canales, Shellsea (2025)
Wilson, J
ROS prioritizes patient education, transparency, and the ethical application of peptide therapy, offering treatments backed by scientific research and clinical experience
This product is intended for administration by licensed healthcare professionals in a clinical setting
US$ 29.40
US$ 25.43
US$ 21.91
US$ 27.37
US$ 26.96
